Gilead disputes report that anti-coronavirus drug Remdesivir flopped in leaked trial
APRIL 24, 2020 9:28:08 AM
In the Chinese trial remdesivir, given by intravenous infusion, failed to improve patients' condition or reduce the pathogen's presence in the bloodstream, according to draft documents published accidentally by the World Health Organization.
.png)
No hay comentarios:
Publicar un comentario